Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hibero vs Ditropan in Pediatric OAB
NCT06181591Phase 2Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirabegron in overactive bladder (OAB), sponsored by Seoul National University Hospital. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT06181591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06181591.